WHC is still in active development. Read this to understand our approach.
depiction of OUYCCCASQSFEME-UHFFFAOYSA-N.svg
psychonaut

Tyrosine

Check on psychonaut

isomerdesign

Tyrosine

Check on isomerdesign

pubchem

Tyrosine

Check on pubchem

drugmap

L-tyrosine

Check on drugmap

wiki

Tyrosine

Check on wiki

Data

InChI: InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)

Synonyms: AI3-09055,BDBM18129,(S)-3-(4-HYDROXYPHENYL)ALANINE,GTPL4791,H-Tyr-OH,Tyrosine (VAN), L-Tyrosine, monomer,(L)-Tyrosine, DD69927C-C6A8-4BC6-8E9A-0AB423B176E7,L-Tyrosine, homopolymer,Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours,4-Hydroxy-L-phenylalanine,(S)-a-amino-4-hydroxy-Benzenepropanoate,CAS-60-18-4,NCGC00344525-01,(-)-alpha-Amino-p-hydroxyhydrocinnamic acid,SCHEMBL1581, Beta-(p-Hydroxyphenyl)alanine,(S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid,Z756440046,DB00135,Tyrosine, L-,(S)-Tyrosine, P-Tyrosine,T0550,FEMA No. 3736,Tyrosine, L- (8CI),Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide,(S)-alpha-Amino-4-hydroxybenzenepropanoic acid,A832631,(S)-3-(p-Hydroxyphenyl)alanine,AC2634,(S)-alpha-amino-4-hydroxy-Benzenepropanoate,MFCD00002606,4ts1, (S)-Tyrosine,ZINC266964,1189756-47-5,TYROSINE [ORANGE BOOK],42HK56048U,LEVODOPA IMPURITY, L-TYROSINE- [USP IMPURITY],TYROSINE [USP MONOGRAPH],L-(-)-Tyrosine,EINECS 200-460-4,N-acetyl-o-(dihydroxymethylsilyl)-,TYROSINE [WHO-DD],DB-029987,DD69927C-C6A8-4BC6-8E9A-0AB423B176E7, Alpha-Amino-beta-(4-hydroxyphenyl)propionic acid, L-p-Tyrosine,002T606,UNII-42HK56048U,tirosina,Q188017, (-)-alpha-Amino-p-hydroxyhydrocinnamic acid, Tirosina [Spanish], (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid, L-(-)-Tyrosine, Tyrosine [USAN:INN],(-)-a-Amino-p-hydroxyhydrocinnamate,(S)-alpha-Amino-4-hydroxybenzenepropanoate, L-Tyrosine (JAN),L-TYR-OH,2-Amino-3-(4-hydroxyphenyl)propanoic acid, (S)-,2csm,TYROSINE [VANDF],L-Tyr,.alpha.-Amino-.beta.-(4-hydroxyphenyl)propionic acid,Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide,L-TYROSINE [FCC],L-Tyrosine, monomer,NCGC00159350-02,DIETHYL1,3,5-BENZENETRICARBOXYLATE,Levodopa related compound l-tyrosine, Tyrosine (USP/INN), TYR NH3+ COOH,tyrosine,Benzeneethanaminium,a-carboxy-4-hydroxy-N,N,N-trimethyl-,inner salt,(as)-, Tyrosinum [Latin],J-521656,Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid,D70837, Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide,AC-11295,L-Tyrosine, reagent grade, >=98% (HPLC),Levodopa impurity, l-tyrosine-,Tox21_111594,BP-13285,L-Tyrosin,DSSTox_GSID_23730, Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction,CS-8013, Tyrosine (VAN), Tyr,(S)-a-amino-4-hydroxy-Benzenepropanoic acid,alpha-Amino-beta-(4-hydroxyphenyl)propionic acid,plovamer-acetate,(-)-.alpha.-Amino-p-hydroxyhydrocinnamic acid,TYROSINE [HSDB],Tox21_111594_1,C00082,L-TYROSINE [FHFI],2-Amino-3-(4-hydroxyphenyl)propanoic acid-(S)-,NSC-82624, L-Tyrosin, Tyrosinum,(-) tyrosine,(S)-2-Amino-3-(4-hydroxyphenyl)propionic acid,NSC 82624,L-Tyrosine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture, Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours,L-Phenylalanine-4-hydroxy-,Tyrosine, European Pharmacopoeia (EP) Reference Standard,L-TYROSINE [USP-RS],M02963,Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction,L-Tyrosine, Cell Culture Reagent (H-L-Tyr-OH),(S)-alpha-amino-4-hydroxy-Benzenepropanoic acid, Tyrosine, L-(8CI),tyr, Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide,F8889-8713, Rxosine,TYROSINE [MI], L-Tyrosine, homopolymer, H-Tyr-OH, (S)-alpha-Amino-4-hydroxybenzenepropanoic acid,L-Tyrosine non-animal source,(S)-a-Amino-4-hydroxybenzenepropanoic acid,TYROSINE [EP MONOGRAPH],L-Tyrosine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, >=99.0%,L-Tyrosine, SAJ special grade, >=99.0%, Free-Form L-Tyrosine,Tyrosine (L-Tyrosine),LEVODOPA IMPURITY B [EP IMPURITY],Z1250208672, 4ts1,(S)-.alpha.-Amino-4-hydroxybenzenepropanoic acid,L-p-Tyrosine,TYROSINE [II],Benzenepropanoic acid, .alpha.-amino-4-hydroxy-, (S)-,Benzeneethanaminium, a-carboxy-4-hydroxy-N,N,N-trimethyl-,inner salt, (aS)-,Tyrosinum,L-[U-14C]Tyr,α-Carboxy-4-hydroxyphenethylamine, L-Tyrosine (9CI), Tirosina,beta-(p-Hydroxyphenyl)alanine,Benzenepropanoate,Q27115106,AKOS010400205,(S)-a-Amino-4-hydroxybenzenepropanoate,L-2-Amino-3-p-hydroxyphenylpropanoic acid,D00022,L-Tyrosine, BioUltra, >=99.0% (NT),TYROSINE [INN],(2S)-2-amino-3-(4-hydroxyphenyl)propanoicacid,DSSTox_CID_3730,bmse000051,(-)-alpha-Amino-p-hydroxyhydrocinnamate,H-Tyr,(-)-a-Amino-p-hydroxyhydrocinnamic acid,60-18-4,alpha-Amino-4-hydroxybenzenepropanoic acid, (S)-,CHEBI:17895,Tirosina [Spanish],2-amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoic acid,Propanoic acid, 2-amino-3-(4-hydroxyphenyl)-(S)-, Tyrosine Power,p-Tyrosine,Tyrosine [USAN:INN],Propanoic acid, 2-amino-3-(4-hydroxyphenyl)-, (S)-,Benzenepropanoic acid, alpha-amino-4-hydroxy-, (S)-,L-Phenylalanine, 4-hydroxy-, 4-Hydroxy-L-phenylalanine,L-Tyrosine (9CI),TYROSINE [USAN],HY-N0473,HSDB 2003,2-amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoate,25619-78-7,NCGC00159350-03,L-Tyrosine, Vetec(TM) reagent grade, >=98%,s4608,CHEMBL925,Tyrosine,DTXSID1023730,EN300-52629,3-(4-Hydroxyphenyl)-L-alanine, 2-Amino-3-(p-hydroxyphenyl)propionic acid,Tyrosinum [Latin],L-Tyrosine,(S),DSSTox_RID_77170,L-Tyrosine, certified reference material, TraceCERT(R), (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid,(S)-2-Amino-3-(p-hydroxyphenyl)propionate,DTY,AM82304,TYROSINE [INCI],L-tyrosine,L-Tyrosine, >=97%, FG,alpha-Amino-p-hydroxyhydrocinnamic acid, (-)-, L-Tyrosine hydrochloride,L-Tyrosine, Free Base - CAS 60-18-4,L-Tyrosine, United States Pharmacopeia (USP) Reference Standard,L-Tyrosine, Vetec(TM), 98.5%, L-2-Amino-3-p-hydroxyphenylpropanoic acid, Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs,(S)-(-)-Tyrosine,L-TYROSINE [JAN],N-ACETYLTYROSINE IMPURITY A [EP IMPURITY], 3-(p-Hydroxyphenyl)alanine,TYROSINE [MART.], Tyrosine,AS-11772,L-Tyrosine (JP17), 3-(4-Hydroxyphenyl)-L-alanine, (S)-3-(p-Hydroxyphenyl)alanine,Tyrosine (USP/INN)

Estimated data

Solubility: -1.081 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 31.5% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.